Argitalpenak (45) BERNARDO MORENO LOPEZ argitalpenak

filter_list

2022

  1. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

    Brain Pathology, Vol. 32, Núm. 3

2021

  1. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 7, pp. 1004-1018

  2. Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage Motoneuron Excitability

    Frontiers in Molecular Neuroscience, Vol. 14

2020

  1. Nitric oxide controls excitatory/inhibitory balance in the hypoglossal nucleus during early postnatal development

    Brain Structure and Function, Vol. 225, Núm. 9, pp. 2871-2884

2019

  1. Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1

    Nature Communications, Vol. 10, Núm. 1

2018

  1. XXXIX Congress of the Spanish Society of Physiological Sciences (SECF), 18-21 September 2018, Cádiz, Spain ed. lit.

    Journal of physiology and biochemistry

2015

  1. Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo

    Neuropharmacology, Vol. 92, pp. 69-79

  2. Membrane-Derived Phospholipids Control Synaptic Neurotransmission and Plasticity

    PLoS Biology, Vol. 13, Núm. 5

2014

  1. Retrograde response in axotomized motoneurons: Nitric oxide as a key player in triggering reversion toward a dedifferentiated phenotype

    Neuroscience, Vol. 283, pp. 138-165

2012

  1. Endogenous rho-kinase signaling maintains synaptic strength by stabilizing the size of the readily releasable pool of synaptic vesicles

    Journal of Neuroscience, Vol. 32, Núm. 1, pp. 68-84

2011

  1. NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: Modeling a molecular mechanism

    Molecular Neurobiology, Vol. 43, Núm. 1, pp. 41-66

  2. NOS antagonism using viral vectors as an experimental strategy: implications for in vivo studies of cardiovascular control and peripheral neuropathies.

    Methods in molecular biology (Clifton, N.J.), Vol. 704, pp. 197-223

  3. Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis

    Brain Pathology, Vol. 21, Núm. 1, pp. 1-15

  4. Role of tau protein on neocortical and hippocampal oscillatory patterns

    Hippocampus, Vol. 21, Núm. 8, pp. 827-834

2010

  1. Evidence for endothelial nitric oxide as a negative regulator of Schwann cell dedifferentiation after peripheral nerve injury

    Neuroscience Letters, Vol. 471, Núm. 2, pp. 119-124

  2. Local isoform-specific NOS inhibition: A promising approach to promote motor function recovery after nerve injury

    Journal of Neuroscience Research, Vol. 88, Núm. 9, pp. 1846-1857

  3. Nitric oxide induces pathological synapse loss by a protein kinase G-, Rho kinase-dependent mechanism preceded by myosin light chain phosphorylation

    Journal of Neuroscience, Vol. 30, Núm. 3, pp. 973-984

  4. Tau protein role in sleep-wake cycle

    Journal of Alzheimer's Disease, Vol. 21, Núm. 2, pp. 411-421

  5. Transgenic neuronal nitric oxide synthase expression induces axotomy-like changes in adult motoneurons

    Journal of Physiology, Vol. 588, Núm. 18, pp. 3425-3443

2008

  1. Age-dependent effect of nitric oxide on subventricular zone and olfactory bulb neural precursor proliferation

    Journal of Comparative Neurology, Vol. 506, Núm. 2, pp. 339-346